Medicines Commission of india has issued a warning against the use of Meftal pain reliever. Meftal is a commonly used pain reliever that is known to provide quick relief from many problems such as menstrual cramps and headaches. In this situation, the indian Pharmaceutical Commission (IPC) has issued a warning against the use of this pain reliever. The Pharmacovigilance Program of india (PvPI), which monitors and collects information on adverse drug reactions (ADRs) and adverse events associated with pharmaceutical products, in its 'preliminary study' has found that Meftal drug mefenamic acid induces drug reactions with eosinophilia and systemic symptoms. This is called DRESS syndrome.
"Health professionals, patients, and consumers are advised to closely monitor the possibility of the above-mentioned adverse drug reactions (ADR) associated with the use of the above-suspected drug," the warning said.
What is DRESS Syndrome?
DRESS syndrome refers to drug allergy with eosinophilia and systemic symptoms. It is also considered dangerous as a major drug allergy. This disease, which first appears as a rash on the skin, can also affect your organs. Therefore, it is important to avoid drugs that lead to such allergic reactions. Often the liver and other internal organs are affected by the reaction.
Swollen lymph nodes
It also affects the functioning of many organs
It is an allergic reaction that can lead to inflammation of the skin and other organs. "DRESS syndrome is a delayed T-cell mediated hypersensitivity reaction to certain drugs. The damage is caused by an overreaction of the immune system that involves the activation of T-cells and the release of cytokines.